• Policy
• Samsung Bioepis' biosimilar for Avastin was first approved
• by Lee, Tak-Sun Mar 16, 2021 06:21am

• Policy
• COVID-19 vaccine vaccination rate has exceeded 64%
• by Kim, Jung-Ju Mar 15, 2021 08:24am

• Policy
• Cases of Vivozon & Binex need ‘1+3 Regulation Act’
• by Lee, Jeong-Hwan Mar 15, 2021 06:29am

• Company
• SGLT-2 inhibitor Jardiance to expand HF indication
• by Eo, Yun-Ho Mar 15, 2021 06:28am

• Policy
• AZ vaccination recommended for age 65 or older
• by Kim, Jung-Ju Mar 15, 2021 06:28am

• Company
• HER2 targeted therapy market exceeds KRW 200 billion
• by An, Kyung-Jin Mar 15, 2021 06:28am

• Policy
• MFDS drug review result to be disclosed within 2 months
• by Lee, Tak-Sun Mar 12, 2021 06:23am

• Policy
• 3 drugs including Baricitinib are covered for COVID-19 tx
• by Kim, Jung-Ju Mar 12, 2021 06:22am

• Company
• 3 companies have abandoned Pelubi's patent challenge
• by Kim, Jin-Gu Mar 12, 2021 06:22am

• Policy
• SK-manufactured AZ vaccines for export exceeds domestic use
• by Lee, Tak-Sun Mar 12, 2021 06:22am